May 02, 2013, 06.26 PM | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Havells India.
Sudarshan Sukhani (more)
Technical Analyst, s2analytics.com | Capital Expertise: Equity - Technical
Sukhani told CNBC-TV18, "The market is up so today there is no need to go and experiment with a short position. We want to buy Havells India. It has moved out of a consolidation. It was already in an uptrend, so the breakout is a continuation of the existing uptrend. Any breakout has some momentum, may be by today 3.30 PM that momentum should give us some points on the long side."
He further added, " Aurobindo Pharma has made a very attractive bullish breakout, it is an ascending triangle. Such breakouts usually tell us that a significant up move is coming, so it is worthwhile getting in today as this move is just beginning to take shape."
The company had posted a net profit of Rs 106.83 c
Sudarshan Sukhani of s2analytics.com is of the vie
Havells India Ltd has informed BSE that the 33rd A
Havells India Ltd has informed BSE that a meeting
Speaking to CNBC-TV18 Saurabh Goel, Executive VP o